| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/20/2007 | US7192715 Diagnostics and therapy of epstein-barr virus in autoimmune disorders |
| 03/20/2007 | US7192711 using tumor-associated genes and encoded gene products in tumor diagnosis |
| 03/20/2007 | US7192706 Growth regulating proteins |
| 03/20/2007 | US7192705 Nucleotide sequences coding transmembrane cochlear-expressed gene 1(TDC1) protein for use in diagnosis, prognosis and treatment of hearing loss |
| 03/20/2007 | US7192702 Modulators of the interaction between Arp2/3 and cortactin or HS-1 |
| 03/20/2007 | US7192597 comprising fatty compound, quaternary ammonium compound and S-adenosylmethionine |
| 03/20/2007 | US7192596 Recombinant toxin fragments |
| 03/20/2007 | US7192594 Postweaning multisystemic wasting syndrome and porcine circovirus from pigs |
| 03/20/2007 | US7192592 administering protein comprising a first polypeptide disulfide-bonded to a second polpeptide, wherein each of said first and second polypeptides comprises amino acid residues 258 to 370 of SEQ ID NO:2 and wherein said protein is mitogenic or chemotactic for mesenchymal cells |
| 03/20/2007 | US7192590 Compounds for treatment of infectious and immune system disorders and methods for their use |
| 03/20/2007 | US7192589 Treatment of inflammatory disorders with STIgMA immunoadhesins |
| 03/20/2007 | US7192584 Therapy of psoriasis in a human comprising administering human necrosis factor (TNF)-inhibiting amount of an anti-TNF antibody, wherein anti-TNF antibody competitively inhibits binding of TNF to monoclonal antibody cA2 |
| 03/20/2007 | US7192580 Purging of cells using viruses |
| 03/20/2007 | US7192578 By administering antiinflammatory drugs |
| 03/20/2007 | US7192576 neurotrophic activity; expression vector; facilitates proliferation, differentiation and/or survival of a cell |
| 03/20/2007 | US7192570 Compositions of somatostatin analogues |
| 03/20/2007 | CA2315115C Compositions of microspheres for wound healing |
| 03/20/2007 | CA2180954C Inhibitors of human plasmin derived from the kunitz domains |
| 03/20/2007 | CA2002868C Single domain ligands, receptors comprising said ligands, methods for their production, and use of said ligands and receptors |
| 03/16/2007 | WO2006028277A1 A pharmaceutical composition for treating ataxia, multiple system atrophy or balance disorders |
| 03/15/2007 | WO2007030834A1 Chimeric hcn channels |
| 03/15/2007 | WO2007030804A1 Prion-specific peptoid reagents |
| 03/15/2007 | WO2007030706A1 Fragments of the glucagon-like peptide-i and uses thereof |
| 03/15/2007 | WO2007030697A2 Modulation of neurogenesis by hdac inhibition |
| 03/15/2007 | WO2007030658A2 Compositions useful for and methods of modulating angiogenesis |
| 03/15/2007 | WO2007030651A1 Mammary secreted protein for cancer treatment |
| 03/15/2007 | WO2007030602A2 Treatment of b cells with il-21 and b cell activators induces granzyme b production |
| 03/15/2007 | WO2007030577A2 Prodrugs of t3 and t4 with enhanced bioavailability |
| 03/15/2007 | WO2007030573A2 Polypeptides useful for molecular weight determinations |
| 03/15/2007 | WO2007030492A2 Method for the treatment of infection with hhv-6 virus and the amelioration of symptoms related to virus using liposomal encapsulation for delivery of reduced glutathione |
| 03/15/2007 | WO2007030475A1 Methods for treating immune mediated neurological diseases |
| 03/15/2007 | WO2007030307A2 Method of treating glaucoma |
| 03/15/2007 | WO2007030290A2 Cristin/r-spondin ligands active in the wnt signaling pathway and methods, compositions and kits relating thereto |
| 03/15/2007 | WO2007030145A2 Elastin protective polyphenolics and methods of using the same |
| 03/15/2007 | WO2007030082A1 Use of des-aspartate-angiotensin i |
| 03/15/2007 | WO2007030035A1 Agent for correcting stress-inducing neuro-mediator, neuro- endocrine and metabolic disturbances and method for preventing and treating concomitant pathological conditions |
| 03/15/2007 | WO2007029631A1 Composition for amelioration of body lipid |
| 03/15/2007 | WO2007029238A2 Methods and compositions for oral administration of proteins |
| 03/15/2007 | WO2007029041A2 Interferon lambda therapy for treatment of respiratory diseases |
| 03/15/2007 | WO2007029003A2 Method of preparing a hydrogel |
| 03/15/2007 | WO2007028969A2 Anchoring disruption molecules |
| 03/15/2007 | WO2007028968A1 Method of treating myasthenia gravis |
| 03/15/2007 | WO2007028632A2 Analogs of gastric inhibitory polypeptide as a treatment for age related decreased pancreatic beta cell function |
| 03/15/2007 | WO2007028573A1 Tumor-associated peptides binding to human leukocyte antigen (hla) class i or ii molecules and related anti-cancer vaccine |
| 03/15/2007 | WO2007028244A1 Modified biodegradable polymers, preparation and use thereof for making biomaterials and dressings |
| 03/15/2007 | WO2007028223A1 Lopap-based pharmaceutical compositions and uses thereof |
| 03/15/2007 | WO2007028219A1 Epitopes, combined epitopes, use of epitopes or their combination, composition, uses of the composition, anti- hiv-i prophylactic vaccines, therapeutic vaccines, method for the identification of epitopes and methods for treatment and prevention |
| 03/15/2007 | WO2007028212A1 Noggin and chimeric molecules thereof |
| 03/15/2007 | WO2007028211A1 Composition of whey growth factor extract for reducing muscle inflammation |
| 03/15/2007 | WO2007028210A1 Milk derived composition and use to enhance muscle mass or muscle strength |
| 03/15/2007 | WO2006132925A3 Method of amidated peptide biosynthesis and delivery in vivo: endomorphin-2 for pain therapy |
| 03/15/2007 | WO2006127284A3 Method of purifying apo-2 ligand/trail using crystallisation in the cold |
| 03/15/2007 | WO2006126025A3 Cytokine |
| 03/15/2007 | WO2006119013A3 Nogo receptor functional motifs and peptide mimetics related thereto and methods of using the same |
| 03/15/2007 | WO2006116737A3 Compounds and methods for modulating cadherin-mediated processes |
| 03/15/2007 | WO2006103429A3 High affinity hiv t cell receptors |
| 03/15/2007 | WO2006099451A3 Novel human, feline, chicken and other animal interferons and uses thereof |
| 03/15/2007 | WO2006094103A3 Methods for treating and diagnosing susceptibility to cytosolic pathogens |
| 03/15/2007 | WO2006089966A3 Fxiii variants with improved properties |
| 03/15/2007 | WO2006088832A3 Methods for the treatment of sepsis and sepsis-associated cardiac dysfunction |
| 03/15/2007 | WO2006061853A3 Novel erythropoietic compounds and a process for producing erythropoietic compounds |
| 03/15/2007 | WO2006026785A3 COMPOSITIONS AND METHODS FOR MODULATING PGC-1α TO TREAT NEUROLOGICAL DISEASES AND DISORDERS |
| 03/15/2007 | WO2006005757A3 Blood pressure lowering oligopeptides |
| 03/15/2007 | WO2005007831A3 Compositions of protein mimetics and methods of using same against hiv-1, sars-cov and the like |
| 03/15/2007 | WO2004103295A3 Interleukin-9 antagonist muteins and their pharmacological methods of use |
| 03/15/2007 | WO2004091499A3 Intracellular formation of peptide conjugates |
| 03/15/2007 | WO2004072100A3 Nell peptide expression systems and bone formation activity of nell peptide |
| 03/15/2007 | WO2003093432A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 03/15/2007 | US20070061923 Polypeptides having antimicrobial activity and polynucleotides encoding same |
| 03/15/2007 | US20070061920 Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes |
| 03/15/2007 | US20070061901 Methods to inhibit growth of prostate cancer cells |
| 03/15/2007 | US20070060635 Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents |
| 03/15/2007 | US20070060541 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections |
| 03/15/2007 | US20070060538 Gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening |
| 03/15/2007 | US20070060530 Administration of dipeptidyl peptidase inhibitors |
| 03/15/2007 | US20070060529 Administration of dipeptidyl peptidase inhibitors |
| 03/15/2007 | US20070060528 Administration of dipeptidyl peptidase inhibitors |
| 03/15/2007 | US20070060527 Orally administered small peptides synergize statin activity |
| 03/15/2007 | US20070060526 Methods of facilitating neural cell survival using non-peptide and peptide BDNF neurotrophin mimetics |
| 03/15/2007 | US20070060525 Thio-containing inhibitors of aminopeptidase P, compositions thereof and method of use |
| 03/15/2007 | US20070060524 Analogs of peptides corresponding to class I major histocompatibility complex (MHC)-restricted T-cell epitopes that contain amino acid substitutions of norleucine and/or norvaline; intranodal administration a an immunopotentiating agent |
| 03/15/2007 | US20070060523 Preparation of poly(4-aminopyrrole-2-carboxamide) having the terminal amide group substituted with a 2-amidinoethyl- group; amidating the carbonyl chloride with 2-aminopropionitrile and subjecting the product to the Pinner reaction |
| 03/15/2007 | US20070060522 Soluble fibrin inhibitory peptides and uses thereof |
| 03/15/2007 | US20070060521 Inhibition of STAT3 signal transduction for human cancer therapy |
| 03/15/2007 | US20070060520 Use of anti-prolactin agents to treat proliferative conditions |
| 03/15/2007 | US20070060519 Hsp therapy in conjunction with a low antigenicity diet |
| 03/15/2007 | US20070060518 Immunogens; plasmids; directly interact with major histocompatability complex, improving immunology |
| 03/15/2007 | US20070060517 Methods for preventing and treating local tracheal, bronchial or alveolar bleeding or hemoptysis |
| 03/15/2007 | US20070060516 may stimulate the immune system and may be used for treating malignancies associated with overexpression of the HER-2 protein, including epitopes of the HER-2 proteins; breast cancer treatment |
| 03/15/2007 | US20070060515 Epithelial cell specific growth factor keratinocyte growth factor (KGF) |
| 03/15/2007 | US20070060514 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 03/15/2007 | US20070060513 Method for increasing the serum half-life of a biologically active molecule |
| 03/15/2007 | US20070060512 Dipeptidyl-peptidase protected protein |
| 03/15/2007 | US20070060511 Combinations of immunosupressive agents for the treatment or prevention of graft rejections |
| 03/15/2007 | US20070060510 for complex formation of hepatitis C non-structural protein-3 (NS3) with NS4A; enhancing the proteolytic efficacy at all of the sites; prevent reproduction of hepatitis virus |
| 03/15/2007 | US20070060509 Endoparasiticidal compositions for topical application |
| 03/15/2007 | US20070060508 Binding molecules |
| 03/15/2007 | US20070060507 Growth factor homolog zvegf3 |
| 03/15/2007 | US20070060506 Compositions and methods for treating bacteria |
| 03/15/2007 | US20070060505 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections |